Sentence examples for reduction in total mortality from inspiring English sources

The National Lung Screening Trial has achieved a 7% reduction in total mortality with low-dose computed tomography (LDCT) screening as compared with in the chest radiography arm.

In aggregate, the fish oil trials demonstrated a reduction in total mortality and sudden death without a clinically significant reduction in nonfatal myocardial infarction.

In conclusion, the evidence suggests a role for fish oil (eicosapentaenoic acid, docosahexaenoic acid) or fish in secondary prevention because recent clinical trial data have demonstrated a significant reduction in total mortality, coronary heart disease death, and sudden death.

Belt use was associated with a 67.0% reduction in total mortality.

In multilevel, multivariable models that adjusted for the clustering of rear occupants traveling in the same vehicles, rear passenger restraint use was associated with a 67% reduction in total mortality (Table 3).

While we observed a significant 10% reduction in total mortality in our sample, this effect was less robust to missing data in sensitivity analysis and provides some evidence to support the hypothesis that the effect of cardiac rehabilitation on total mortality may be attenuated when considering a wider range of participants in the modern treatment era.

In particular, increases in the adult literacy rate produce sharply lower infant and child mortality rates and less dramatic reductions in total mortality rates.

This argument is in agreement with the most recent Cochrane review on the topic where a trend was observed via meta-regression for smaller reductions in total mortality with cardiac rehabilitation trials published in more recent years [8].

While earlier meta-analyses found significant reductions in total mortality of up to 20 30% [12, 15, 102, 103], the most recent review [8], which represented a broader range of participants and trials conducted in the modern treatment era, failed to find such a benefit.

A sub-analysis of 6748 patients with PAD in the Heart Protection Study showed significant reductions in total mortality, vascular mortality, coronary heart disease events, strokes, and non-coronary revascularization in those treated with simvastatin (77).

When compared with placebo, secondary endpoints reduced with perindopril treatment included a 14% reduction (P=0.0009) in total mortality, nonfatal MI, unstable angina and cardiac arrest, and a 39% reduction (P=0.002) in hospital admission for heart failure.